Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela R Smith

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Transplantation and Cellular Therapy|September 20, 2020
Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell TransplantationPaul G Richardson, Angela R Smith, Nancy A Kernan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2016
Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic DisordersKanwaldeep K Mallhi, Angela R Smith, Todd E DeFor, et al.
Pediatric Blood & Cancer|April 19, 2008
Familial hemophagocytic lymphohistiocytosis in two brothers with X-linked agammaglobulinemiaKris Ann P Schultz, Joseph P Neglia, Angela R Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donorsAngela R Smith, K Scott Baker, Todd E Defor, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent mannerAngela R Smith, Jesus A Alonso, Cory M Ayres, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 9, 2021
<i>CYP51A1</i> polymorphism and voriconazole-associated hepatotoxicity in children undergoing hematopoietic cell transplantTakuto Takahashi, Angela R Smith, Pamala A Jacobson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 14, 2012
Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantationJan Vydra, Ryan M Shanley, Ige George, et al.
Journal of Clinical Pharmacology|November 24, 2011
Population pharmacokinetics of unbound mycophenolic acid in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantationHyewon Kim, Janel Long-Boyle, Nancy Rydholm, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 22, 2019
Reduced-Toxicity (BuFlu) Conditioning Is Better Tolerated but Has a Higher Second Transplantation Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic DisordersAshish Gupta, Michael Downey, Ryan Shanley, et al.
British Journal of Haematology|March 12, 2020
Pooled analysis of Day 100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantationPaul G Richardson, Angela R Smith, Nancy A Kernan, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Transplantation and Cellular Therapy|September 20, 2020
Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell TransplantationPaul G Richardson, Angela R Smith, Nancy A Kernan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2016
Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic DisordersKanwaldeep K Mallhi, Angela R Smith, Todd E DeFor, et al.
Pediatric Blood & Cancer|April 19, 2008
Familial hemophagocytic lymphohistiocytosis in two brothers with X-linked agammaglobulinemiaKris Ann P Schultz, Joseph P Neglia, Angela R Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donorsAngela R Smith, K Scott Baker, Todd E Defor, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent mannerAngela R Smith, Jesus A Alonso, Cory M Ayres, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 9, 2021
<i>CYP51A1</i> polymorphism and voriconazole-associated hepatotoxicity in children undergoing hematopoietic cell transplantTakuto Takahashi, Angela R Smith, Pamala A Jacobson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 14, 2012
Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantationJan Vydra, Ryan M Shanley, Ige George, et al.
Journal of Clinical Pharmacology|November 24, 2011
Population pharmacokinetics of unbound mycophenolic acid in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantationHyewon Kim, Janel Long-Boyle, Nancy Rydholm, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 22, 2019
Reduced-Toxicity (BuFlu) Conditioning Is Better Tolerated but Has a Higher Second Transplantation Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic DisordersAshish Gupta, Michael Downey, Ryan Shanley, et al.
British Journal of Haematology|March 12, 2020
Pooled analysis of Day 100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantationPaul G Richardson, Angela R Smith, Nancy A Kernan, et al.
Pageof 7